Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
CFX - Colfax Corp
0.51(1.27%)9:00:02 PM 1/22/2021
Colfax Corporation is an American corporation manufacturing welding, air and gas handling equipment, and medical devices headquartered in Annapolis Junction, Maryland. Indexed on the NYSE, the company was originally founded as a spinoff from the American conglomerate Danaher Corporation. In 2011, Colfax acquired British Charter International PLC, which in turn owned Swedish ESAB . Both companies have since been wholly owned by Colfax. Further Colfax also acquired Allweiler . The company made its largest acquisition ever in November 2018, buying medical device company DJO Global for $3.15 billion. Colfax was founded in 1995 by Steven and Mitchell Rales.
Stock Chart


  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics


Stock news

    Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical

    Colfax (CFX) arm DJO closes buyout of Trilliant Surgical, which will boost its product offerings and growth prospects in the foot and ankle surgery market.

    DJO® Acquires Trilliant Surgical

    DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical’s leading product technologies and clinical efficacy supports DJO’s focused expansion into the adjacent high-growth $1 billion US foot and ankle market.

    5 Industrial Stocks Near 52-Week Highs That Can Scale Higher

    The industrial sector is gearing up for growth in 2021. ParkerHannifin (PH), Fortune Brands (FBHS), Reliance Steel (RS), Rexnord (RXN) and Colfax (CFX) are performing well and are set to grow.

    Is Colfax (CFX) a Profitable Stock for Value Investors Now?

    Let's see if Colfax (CFX) stock is a good choice for value-oriented investors right now from multiple angles.

    Is There An Opportunity With Colfax Corporation's (NYSE:CFX) 37% Undervaluation?

    How far off is Colfax Corporation ( NYSE:CFX ) from its intrinsic value? Using the most recent financial data, we'll...

    Is CFX A Good Stock To Buy Now?

    Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]

    Colfax (CFX) Arm's LiteCure Buyout to Boost Product Portfolio

    Colfax's (CFX) acquisition of LiteCure will create strong growth opportunities for DJO in the physical therapy and rehabilitation market.

    DJO® Acquires LiteCure Laser Therapy

    DJO, LLC ("DJO" or the "Company"), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of LiteCure®, the market leader in therapeutic laser technology for human and animal health.​ This purchase further extends DJO’s strength as the global market leader in recovery sciences and allows the company to deliver unparalleled innovation to its customers and their patients.

    Colfax (CFX) to Gain From Products & Buyouts Amid Pandemic Woes

    Colfax's (CFX) product launches, exposure in multiple markets and gains from buyouts to prove beneficial. However, the pandemic-led challenges and lower selling days remain concerning for Q4.